76397-9
LaboratoryLymph node involvement
Definition
Patients are allocated into two risk groups based on lymph node involvement; the risk group for node-negative patients, and the risk group for node-positive (1-3) patients. This term was created for, but not limited in use to, the Prosigna Breast Cancer Prognostic Gene Signature assay, which is based on the reported 50-gene classifier algorithm originally named PAM50.
LOINC 6-Axis Classification
Component
Lymph node involvement
Property
Find
Time Aspect
Pt
System
Lymph node
Scale Type
Ord
Method Type
N/A
Details
Class
PATH
Order/Observation
Observation
Short Name
LN involved LN Ql
Display Name
Lymph node involvement Ql (Lymph node)
Related Names
Frequently Asked Questions
What is LOINC code 76397-9?
LOINC code 76397-9 identifies "Lymph node involvement". Patients are allocated into two risk groups based on lymph node involvement; the risk group for node-negative patients, and the risk group for node-positive (1-3) patients. This term was created for, but not limited in use to, the Prosigna Breast Cancer Prognostic Gene Signature assay, which is based on the reported 50-gene classifier algorithm originally named PAM50.
What does 76397-9 measure?
This code measures Lymph node involvement in Lymph node. It belongs to the PATH class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.